Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,000
Closed -$326K 6023
2022
Q2
$326K Hold
6,000
﹤0.01% 3551
2022
Q1
$327K Sell
6,000
-1,246,240
-100% -$67.7M ﹤0.01% 3786
2021
Q4
$69M Buy
1,252,240
+1,246,240
+20,771% +$64.8M 0.04% 440
2021
Q3
$287K Hold
6,000
﹤0.01% 3935
2021
Q2
$299K Buy
+6,000
New +$288K ﹤0.01% 4023
2021
Q1
Sell
-88,800
Closed -$4.08M 6716
2020
Q4
$4.08M Sell
88,800
-23,120
-21% -$1.06M ﹤0.01% 2239
2020
Q3
$5.27M Sell
111,920
-65,840
-37% -$3.3M ﹤0.01% 1845
2020
Q2
$9.06M Buy
177,760
+42,800
+32% +$2.2M 0.01% 1375
2020
Q1
$6.39M Buy
134,960
+46,160
+52% +$2.46M 0.01% 1478
2019
Q4
$5.21M Sell
88,800
-16,640
-16% -$926K ﹤0.01% 1988
2019
Q3
$5.63M Sell
105,440
-6,480
-6% -$333K ﹤0.01% 1839
2019
Q2
$5.6M Buy
111,920
+17,120
+18% +$859K ﹤0.01% 1875
2019
Q1
$4.95M Sell
94,800
-30,960
-25% -$1.55M ﹤0.01% 1795
2018
Q4
$6.01M Sell
125,760
-24,960
-17% -$1.23M 0.01% 1666
2018
Q3
$7.57M Sell
150,720
-18,960
-11% -$963K 0.01% 1485
2018
Q2
$8.55M Sell
169,680
-109,280
-39% -$5.5M 0.01% 1413
2018
Q1
$13.6M Buy
278,960
+139,840
+101% +$6.51M 0.01% 1027
2017
Q4
$6.17M Sell
139,120
-13,120
-9% -$606K ﹤0.01% 1644
2017
Q3
$7.73M Sell
152,240
-31,920
-17% -$1.62M 0.01% 1407
2017
Q2
$9.93M Sell
184,160
-51,040
-22% -$2.72M 0.01% 1146
2017
Q1
$12.4M Sell
235,200
-95,600
-29% -$4.85M 0.01% 994
2016
Q4
$15.9M Buy
330,800
+165,840
+101% +$8.19M 0.01% 895
2016
Q3
$8.89M Buy
164,960
+23,600
+17% +$1.29M 0.01% 1172
2016
Q2
$7.66M Sell
141,360
-41,120
-23% -$2.17M 0.01% 1224
2016
Q1
$9.25M Sell
182,480
-162,000
-47% -$8.07M 0.01% 1066
2015
Q4
$17.4M Buy
344,480
+80,160
+30% +$4.09M 0.02% 804
2015
Q3
$12.7M Sell
264,320
-25,760
-9% -$1.34M 0.01% 988
2015
Q2
$15.1M Buy
290,080
+63,600
+28% +$3.58M 0.01% 951
2015
Q1
$13.1M Sell
226,480
-58,160
-20% -$3.33M 0.01% 1009
2014
Q4
$15.2M Sell
284,640
-59,440
-17% -$3.33M 0.01% 967
2014
Q3
$19.8M Buy
344,080
+88,800
+35% +$5.44M 0.02% 815
2014
Q2
$17.1M Buy
255,280
+90,800
+55% +$6.15M 0.02% 893
2014
Q1
$11M Sell
164,480
-26,000
-14% -$1.76M 0.01% 1087
2013
Q4
$12.7M Buy
190,480
+21,040
+12% +$1.36M 0.01% 1069
2013
Q3
$10.6M Buy
169,440
+67,520
+66% +$4.35M 0.01% 1121
2013
Q2
$6.37M Buy
+101,920
New +$6.47M 0.01% 1412

Other funds holding GSK

Citigroup's GSK Position: Q1 2026 in Review

Citigroup increased its GSK (GSK) stake by 675% in Q1 2026, buying an estimated $70.6M and bringing the position to 1,496,097 shares worth $82.6M. The position accounts for 0.04% of the portfolio, ranked #466.

Citigroup first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $103M in Q1 2024. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Citigroup held 1,496,097 shares of GSK worth $82.6M as of Q1 2026.
  • Citigroup bought 1,303,067 GSK shares in Q1 2026, an estimated $70.6M.
  • GSK made up 0.04% of Citigroup's portfolio in Q1 2026, its #466 holding.
  • Citigroup first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Citigroup's GSK position peaked at $103M in Q1 2024.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.